A total of 187 patients with a recently ruptured intracranial aneurysm had subarachnoid hemorrhage confirmed by lumbar puncture. A group of 124 patients were assigned to treatment within 7 days after the bleed, 49 between 8 and 21 days, and 14 between 22 days and 92 days.
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mouth, nasogastric tube, or intravenously; (10) maintenance of 1,000 calories of nutrition per day, either by oral diet or tube feeding formula; (11) if sedation was required for restlessness, paraldehyde, phenobarbital, or chloral hydrate was administered in usual dosage; (12) condom drainage for men and catheter drainage for women was ordered for patients with incontinence; (13) proper analgesia was maintained by administration of acetylsalicylic acid, codeine, or meperidine hydrochloride; (14) every effort was made by each contributing center to provide a sustained high standard of nursing care encompassing frequent checking of vital signs, level of responsiveness, neurological assessment of verbal requests, pupil size, reactivity to light, ability to move extremities, and relative strength of grip; and (15) no agents such as osmotic diuretics, corticosteroids, or similar medications were permitted. No response to address or shaking, nonadaptive response to noxious stimuli, and progressive instability of vital signs
Results
Mortality was 55.1% among the 187 patients treated with regulated bed rest during a mean follow-up interval of 6.5 years. The highest mortality (62.9%) occurred in patients allocated to treatment within 7 days after the last bleed (table 6) . Mortality among patients who were allocated to treatment during the 8 to 21-day interval and 22 to 92-day interval was considerably less (39.6% and 35.7%, respectively). Mortality among patients with an internal carotid aneurysm was 51.4%; for those with a middle cerebral aneurysm it was 59.1%, and in the group with an aneurysm on the anterior cerebral complex it was 55.4% (table 6) . These figures are not significantly different. Among the group of patients who were hospitalized and who had their diagnostic workup completed within one week after onset of symptoms, mortality was appreciably higher.
Several clinical parameters were analyzed with respect to potential influence on mortality: age, sex, aneurysm site, neurological and medical conditions, systolic and mean blood pressures, interval between last bleed and randomization, cerebral vasospasm, size of aneurysm, cause of death, and associated medical disorders. In the discussion to follow, each parameter is discussed with respect to mortality and rebleed rate.
Age, sex distribution, and aneurysm site are displayed in tables 7 and 8.
Age and Neurological Condition
The severity of each neurological condition was correlated with respect to age. The age group 50 to 59 had the highest number of patients in each neurological condition (table 9) . As expected, mortality was lowest in grade 1 patients (36.4%) and highest in grade 5 (100%). With each increase in severity of neurological deficit, a proportionate rise in mortality was noted (table 9) . For the group with relatively minor symptoms (grades 1 and 2), 61 died (47.7% of 128), while of those in poor condition (grades 3, 4, and S), 41 died (70.7% of 58). This difference was highly significant (P < 0.01). For patients 50 years of age or over who were in poor neurological condition, the chance of survival was less than 30%.
For all aneurysm sites combined, a proved rebleed was the cause of death in 34.2% (64 of 187) of all patients, or 62.1% of the 103 deaths. Progressive decline in clinical condition following the direct cerebral effects of the original bleed was reported in 8.0% (15 of 187) or 14.6% of 103 deaths. Death following a suspected rebleed was reported in nine patients. Therefore, 47.1% (88 of 187) of deaths were directly related to the cerebral effects of the ruptured aneurysm.
Age and Medical Condition
Some medical conditions were present prior to the onset of symptoms of subarachnoid hemorrhage, while other conditions appeared during the initial phases of the illness. As the specific medical condition was recognized, it was regarded as an associated condition necessary for consideration as the course of treatment was followed.
At the time of treatment allocation, each patient was appraised as to the degree of risk for a major surgical procedure, using the rating scale of good, fair, poor, and prohibitive.
This classification was unrelated to the aneurysm per se. A good condition patient was alert and normotensive. He had no more than a degree of fever and was considered to be in good health prior to his subarachnoid hemorrhage. In general, patients in fair condition had a single underlying medical problem such as hypertension, cirrhosis of the liver, mild to moderate anemia, poor nutrition, generalized atherosclerosis, or chronic pulmonary disease. A patient with more than one adverse medical factor or a single condition which was moderately severe (e.g., recent myocardial infarction, electrolyte abnormalities, malignant hypertension, advanced atherosclerotic disease) was regarded as being in poor condition. Patients in the prohibitive category had a complicated and serious illness with one or more medical disorders.
Among 187 patients, 102 (54.5%) were in good condition, 56 (30.0%) in fair condition, and 26 (13.9%) in poor condition; in 3 patients (1.6%) the medical condition was categorized as prohibitive (table 10) . With an overall mortality of 55.1%, good condition patients alone had a mortality of 44.1%, whereas in fair condition patients it was 60.7%. For patients in poor condition, mortality was 80.8%. All patients with a prohibitive medical status died. Clearly, medical disorders associated with subarachnoid hemorrhage had considerable influence on mortality. This pattern was consistent for all age groups. The number of deaths below age 50 as compared with those age 50 or above revealed the death rate to be significantly higher in the older group. Age was not a significant factor after analyzing the number of deaths above (22 of 45 or 48.9%) or below (23 of 57 or 40.4%) age 50 in good medical condition patients alone. However, for patients in the fair, poor, and prohibitive medical conditions combined, 54.2% (13 of 24) died in the group below age 50, whereas 73.3% (44 of 60) died in the group age 50 or above (P = 0.109).
Patients in good and fair medical conditions had a higher proportion of deaths after a rebleed (70.9%, or 56 of 79, table 11) as compared with patients in poor and prohibitive conditions (33.3%, or 8 of 24). Comparison of the distribution of deaths which followed a proved rebleed among various medical conditions shows no significant difference among all patients in good, fair, or poor medical condition.
Cause of Death
The major cause of death for patients with an aneurysm at various sites was a proved rebleed. Table 12 shows the distribution of the cause of death for each aneurysm site. Evaluation of the interval to death following allocation to formal bed rest therapy revealed that the major proportion of patients died during the three-week period of bed rest. During the first 14 days after randomization, 27 died (26.2% of 103) following a proved rebleed; 40 died (38.8% of 103) within 29 days (table 13) . From day 30 and following, there were 24 more deaths which followed a recurrent hemorrhage (23.3% of 103). Analysis of the remaining causes of death reveals that among the 9 patients who died following a suspected rebleed, 4 succumbed within 14 days after randomization and the remaining 5 after the 44-day interval. Among 15 patients who died following progressive deterioration in clinical condition, 11 deaths were reported within 19 days, and the remaining 4 died after the 44-day interval. Two of these developed hydrocephalus (one required a ventriculopleural shunt), and 2 remained poorly responsive following the last prerandomized bleed. Eight patients died from unrelated causes. Five of these occurred after the one year interval following randomization.
Mortality and Blood Pressure on Day of Randomization
The level of blood pressure as measured within 7 days after the last bleed was another variable which was related to differences in mortality. The average value of four systolic blood pressures taken at intervals of four hours or more were calculated at the Central Registry. For this analysis patients were subdivided into two groups. One group had average The highest percentage of patients who rebled were those allocated to treatment within 7 days and whose average systolic blood pressures were over 140 mm Hg (table 15) . However, these percentages were not different statistically from the group whose blood pressure was 140 mm Hg or below. By comparison with the mortality table (table 14) , a proved rebleed as a cause of death remained the nearest association for patients who were in good neurological condition no matter what the interval following randomization. If systolic blood pressure alone had more direct influence on rebleeding, one would have expected a more direct relationship between mortality and rebleeding.
Recurrent Hemorrhage Following Randomization
The frequency distribution of recurrent hemorrhages as associated with mortality was presented in the previous discussion. Whenever deterioration in mental status and/or neurological condition was noted, a lumbar puncture was performed as conditions permitted. When significant increase in red cell count was noted in the cerebrospinal fluid or recent gross hemorrhage was observed at postmortem ex- 
Interval to Randomization and Recurrent Hemorrhages
Rebleeding was the major cause of morbidity and mor tality during the bed rest treatment period. For all aneurysn sites the group of patients allocated to bed rest within 7 day after last bleed had the highest mortality and rebleed rate i the follow-up period. Patients with an aneurysm on the anterior cerebral complex who were randomized within 7 days had a high rebleed rate. Forty-one per cent rebled during the 53-day interval following the prerandomized bleed (table 17) . Over 20% rebled within 14 days. Patients allocated to bed rest during the 8 to 21-day interval had a lower rebleed rate. Only 22% rebled by the fifty-ninth day following last bleed. None of the seven patients rebled who were allocated to bed rest during the 22 to 92-day interval. Therefore, this interval was not included in table 17.
For all sites combined, for patients randomized following the twenty-first day (when all patients randomized within this interval were allocated to treatment), 10% rebled between day 21 and day 59 (table 17) . Following the initial two-month interval, more patients with an aneurysm on the anterior cerebral-anterior communicating complex rebled than those with an aneurysm at the remaining two major sites. From the third through forty-eighth month following last bleed, nine patients rebled who were allocated to treatment within seven days, and four patients rebled in the group originally allocated to treatment during the 8 to 21-day interval (table 18) . No late rebleeds were reported among patients allocated to treatment within the 22 to 92-day interval. As mentioned previously for the middle cerebral group, one patient rebled on the seventy-fifth day, and one rebled four years later. No other late rebleeds occurred.
Interval to Randomization and Subsequent Mortality
The mortality distribution was variable for specific intervals following last bleed at each aneurysm site. Twenty-five per cent of patients with a middle cerebral aneurysm allocated to bed rest within 7 days actually died within 14 days; 17.2% died in the anterior cerebral group (table 19) . Thirty-six per cent of patients with an internal carotid aneurysm died during that interval. By the twentieth day following last bleed, 21.8% of patients died in the anterior cerebral group. Among those with an internal carotid and middle cerebral aneurysm, the mortality was 40.0% and 50.0%, respectively (table 19) . After the twentieth day, mortality continued to rise gradually among the anterior cerebral group, whereas mortality among patients with an internal carotid and middle cerebral aneurysm remained similar through the sixty-second day. Figure 2 represents schematically the death rate for patients randomized within seven days (table 19) . Mortality between the fifth and twentieth day was most frequent among patients with an internal carotid and middle cerebral aneurysm. However, patients with an anterior cerebral aneurysm had a more gradual rise which did not reach its maximum until the sixty-second day. monthly intervals for all patients with an aneurysm at each location and interval following last bleed. The group of 20 patients who were randomized in the 8 to 21-day and 22 to 92-day intervals with an internal carotid or middle cerebral aneurysm was too small for secondary statistical analysis. However, 20% (4 of 20) died within two months and 35% within four months. A lower rebleed rate was the reason for the lower mortality two months following last bleed in the group of 36 patients with an anterior cerebral aneurysm allocated to treatment during the 8 to 21-day interval. After the sixty-second day mortality stabilized for all groups with the exception of patients allocated to treatment within 7 days with an anterior cerebral-anterior communicating aneurysm. For patients with this aneurysm site, 49 survived the initial 62 days. Between the third and sixtieth month, 18 additional patients (36.7%) died following a rebleed. These data suggest that during the initial eight-week period, patients with an anterior cerebral-anterior communicating aneurysm had a slower rebleed rate than those with an internal carotid or middle cerebral aneurysm. After this eight-week interval patients with an aneurysm on the anterior cerebral complex had comparatively more recurrent hemorrhages than those with aneurysms at the remaining two sites.
Overall Medical Condition of Patients with Ruptured Intracranial Aneurysm
Each medical disorder was reported which existed prior to treatment or which was acquired during treatment. In an earlier section the relationship of mortality to overall medical condition was analyzed. The foregoing analysis includes data on various medical conditions as they relate to age, neurological condition, recurrent hemorrhage, and cause of death. Those conditions recognized prior to or at the time of randomization will be discussed individually from those conditions which developed during the bed rest treatment program.
Medical Disorders at Randomization
Pre-existing hypertension was the most frequently reported medical condition prior to allocation to treatment. No information was supplied with respect to duration or type of antihypertensive medication prescribed.
Internal Carotid Aneurysm
In these 35 patients 9 (25.7%) had known pre-existing hypertension, and in 23 a definite history of hypertension was negative. No information was available in three. Among the nine patients with pre-existing hypertension, two had systolic levels in the range of 160 to 180 mm Hg, two in the range of 180 to 200 mm Hg, and two over 200 mm Hg. In three patients this information was incomplete. Average age in these nine patients was 57.1 years (range 40 to 79). There were two males and seven females. Four patients were in grade 2 neurological condition, two in grade 3, and three in grade 4. One patient was in good medical condition, four were in fair condition, and four in poor condition. Average systolic pressure prior to randomization was 181 mm Hg systolic (range 127 to 215) and 104 mm Hg diastolic (range 8 to 158). Average mean blood pressure was 129 mm Hg. All nine patients had one bleed prior to hospitalization. Eight of the nine patients died: two followed a proved rebleed at 11 and 20 days after the last bleed, respectively; one followed a suspected rebleed; two followed progressive deterioration in clinical condition; and one each died with pneumonia, pulmonary edema, and from unknown cause.
Middle Cerebral Aneurysm
Three of 22 patients (13.6%) had pre-existing hypertension; in 16 patients there was no history of hypertension. No information was available in three. Among the three patients with pre-existing hypertension, one had known systolic levels in the range of 160 to 180 mm Hg, one in the range of 180 to 200 mm Hg, and in one the range was unknown. Average age was 49.0 years (range 42 to 55), and all were females. Two were in grade 2 neurological condition, and one was in grade 5. One patient was in good medical condition, one in fair condition, and one in poor condition.
Average systolic blood pressure at randomization was 145 mm Hg (range 120 to 175), and average diastolic blood pressure was 94 mm Hg (range 79 to 109). Average mean blood pressure was 111 mm Hg. Two patients had had one previous bleed, and one patient had two bleeds. Two patients died 
Summary
This analysis reveals that among a total of 36 patients with known pre-existing hypertension (table 21) 
Cerebral Angiography
The technique of cerebral angiography was not specified according to protocol. Some institutions pursued the angiographic study within several hours of admission to the hospital, while others followed routine scheduling. In spite of these variables, several important factors relating to these procedures were analyzed. These analyses include number of procedures, complications, associated abnormalities (whether or not related to the aneurysm), vasospasm, interval after last bleed to first angiographic procedure, interval after last bleed to randomization, neurological condition, systolic and mean blood pressures, and size of the aneurysm. These analyses are based on the sample of 195 patients. This number includes the 194 patients who completed their course of treatment, plus one patient who was discharged nine days after randomization. Occasionally, a result will be based on a total of 193 patients because insufficient angiographic information was reported on two patients.
Multiple angiographic procedures (more than one) were performed on 57 of 193 patients (29.5%) allocated to bed rest for a number of reasons. These procedures were distributed in similar proportions among the three aneurysm sites. In some institutions each carotid system was studied at separate intervals. Some patients were re-evaluated after deterioration in neurological condition associated with a rebleed or ischemic neurological deficit. Other patients had their vertebral-basilar system visualized angiographically during later procedures. Although the protocol suggested complete cerebral angiographic surveys, vertebral-basilar visualization was completed in only 66 of 193 patients (34.2%). Therefore, the presence of a single aneurysm was certain in these patients only. As each aneurysm was discovered, a complete angiographic survey was not always pursued when the clinical presentation was consistent with the angiographic findings.
The number of multiple angiographic procedures (29.5%) may have been one factor responsible for delay in formal allocation to treatment. Another possible reason for delay was poor neurological and/or medical condition prior to transfer from the local hospital to the participating institution. The distribution was similar in patients allocated to irug-induced hypotension, carotid ligation, and intracranial surgery. The interval from the first angiographic procedure :o the day of randomization (the formal beginning of bed •est) was no more than two days in 69.2%, five days in 85.6%, ind eight days in 92.8%. Assuming that the first angiographic procedure was pursued in a uniform manner at each participating institution, the delay in randomization of more han five days in 14.4% was not unusual. The reasons for lelay in those instances were not clarified. (table 22) . Among patients with an internal carotid aneurysm, two acquired hemiplegia and aphasia. In one patient the condition cleared eventually, and in the other it remained permanent and the patient died. One additional patient had transient hemiparesis which cleared in three hours. No patient rebled or had recognized hypotensive episodes. In the middle cerebral group one patient had temporary hemiplegia and aphasia which cleared in three hours, one acquired permanent hemiparesis, one became poorly responsive without focal manifestations and died, and one had a proved rebleed 18 hours after cerebral angiography. In the anterior cerebral group four patients developed hemiparesis alone; in two the hemiparesis remained permanent, and in two it cleared within three hours. Three patients acquired temporary, dysphasia which cleared in three to six hours. One patient acquired permanent hemiparesis and aphasia, one was lethargic following a left pneumothorax and died four days later, and one had temporary diplopia and increased headache. Three patients rebled, one fatally, and the other two became poorly responsive. One of these two patients died five days later, and the other patient died five months later. One additional patient developed convulsions during the procedure. •Number of patients allocated to each site. tNine patients had more than one angiographic abnormality. _ {Additional patients with miscellaneous findings included four patients with nonfilling of one anterior cerebral artery, one had displacement of midline vessel*, one an occluded right internal carotid artery in the neck, and one a superficial temporal artery aneurysm.
Post-treatment
In summary, five patients (2.6%) died after their rebleed or ischemic deficit. Morbidity was 10.8%. It must be emphasized that the mortality and morbidity were associated with multiple angiographic procedures in acutely ill patients with a hemorrhagic cerebral vascular disorder. Many patients with subarachnoid hemorrhage are also at greater risk than those with an ischemic vascular disorder or with normal intracranial pressure.
Angiographic Abnormalities Associated with the Aneurysm
Abnormalities associated with single ruptured intracranial aneurysms were noted in 52 patients. A total of 54 lesions were reported among all aneurysm sites (table 23) . Intracerebral mass lesions were noted in 12.3% (24 of 195). Most lesions were consistent with a hematoma and/or localized area of cerebral swelling. Sixteen patients (8.2%) had increased sweep of the anterior cerebral vessels; 11 (5.6%) had evidence of an extracerebral mass lesion. Only two patients had an irregular intima consistent with intracranial atherosclerosis, and one had an infundibular dilatation.
For each aneurysm location the most frequent abnormality was an intracerebral mass lesion as determined by angiographic examination. Correlation of intracerebral mass lesions (24), extracerebral mass lesions (11) , and stretching of the anterior cerebral vessels (16) revealed that these lesions occurred 51 times in 54 patients. Such lesions are commonly associated with poor neurological condition. Therefore, one would expect increased mortality with progressive clinical deterioration from direct cerebral effects of the bleed. Among eight patients with an internal carotid aneurysm, six died: four after progressive deterioration in neurological condition and one each from unrelated and unknown cause. Among six patients with a middle cerebral aneurysm, five died: three after a proved rebleed and one each after a suspected rebleed and unrelated cause. Among 31 patients with an anterior cerebral aneurysm, 19 died: 13 after a proved rebleed, three after a suspected rebleed, two from unrelated causes, and one after progressive clinical deterioration. In summary, 30 deaths (66.7% of 45 patients) were associated with these angiographic findings. Sixteen of these deaths followed a proved rebleed, five followed progressive deterioration, four followed a suspected rebleed, and four were from unrelated and one from unknown causes. Comparison of the overall mortality of 55.1% in the bed rest treatment group with the 66.7% figure cannot be regarded as a statistically significant increase. Most deaths (16 of 30) followed a proved rebleed.
Cerebral Vasospasm
The angiographic demonstration of decreased intraarterial size is usually regarded as cerebral vasospasm. Although the primary objective of this study was not the evaluation of vasospasm, the degree of arterial narrowing as interpreted on the cerebral angiogram was reported to the Central Registry. We are cognizant of the pitfalls in the analysis of the data submitted due to variation in the interpretation between one observer and another as to what actually constitutes vasospasm. Cerebral vasospasm was categorized on each angiogram as one of three degrees ol severity: no vasospasm; localized vasospasm (narrowing ol intra-arterial diameter over 1 to 3-cm distances on the proximal portions of the intracranial portion of the internal carotid artery, middle cerebral, anterior cerebral, oi vertebral-basilar artery); and diffuse vasospasm (narrowed diameter of the intracranial internal carotid artery and all the main ipsilateral branches). Various degrees of vasospasm were correlated with age, sex, neurological condition systolic and mean blood pressures, interval from last bleed tc angiography, size of the aneurysm (mm*), and mortality.
Age
The frequency of vasospasm among all aneurysm sites anc age groups was 42.5% (82 of 193). The proportion of patient: with vasospasm increased proportionately with age. A Iov figure of 16.7% was observed in the age group 10 to 19, witl the highest incidence of 57.1% in the age group 60 to 69 (table 24) . Among the seven patients in the age group 70 to 79, only two had localized involvement. Analysis of the entire group below age 50 reveals 36.6% (30 of 82) had some degree of vasospasm, whereas in those patients who were 50 years of age or over, 46.8% had this condition. This difference was not statistically significant. However, vasospasm was present in all age groups, with a higher frequency among the older groups, especially among females (see Discussion, next section).
Sex Distribution
Evaluation of sex distribution with each aneurysm site revealed that patients with an internal carotid aneurysm included 9 males and 28 females. In contrast, the proportion of males and females in the middle cerebral and anterior cerebral groups was very similar (table 25). The distribution of patients with various degrees of vasospasm was proportional among each aneurysm location with the exception of females in the middle cerebral group where four patients had no vasospasm, three had localized vasospasm, and four had diffuse vasospasm. For all aneurysm sites combined, 37% (32 of 87) of men had variable degrees of vasospasm in comparison with 46.7% (50 of 107) of women.
Localized spasm must be clarified, particularly in relation to the A, segment of the anterior cerebral arteries. Differentiation between congenital narrowing of this segment and localized vasospasm was difficult in some instances. Analysis of the patient report forms reveals that unilateral narrowing of the A! segment proximal to the anterior communicating artery was observed in 8 of 37 patients with an aneurysm on the anterior cerebral complex. In two additional instances localized spasm was bilateral, and in one patient with an internal carotid aneurysm it was also bilateral. No instances of selected A, narrowing were reported in the middle cerebral group. Therefore, a total of 11 patients with "localized vasospasm" conceivably had congenital narrowing of the Ai segment. This would reduce the total number of patients with localized and diffuse vasospasm to 71 (36.7% of 193) instead of 82 (42.5%), a difference which is not significant. Therefore, this observation can be disregarded in various correlative analyses. 
Interval from Last Bleed to Initial Angiography
Analysis of the number of patients with and without vasospasm at specific intervals following last bleed revealed that 50% had their initial angiographic procedure within three days after the bleed. During this interval 64 patients (66.0% of 97) had no vasospasm, 23 (23.7%) had localized vasospasm, and 10 (10.3%) had diffuse involvement (table  26) . By comparison, among the 50% who had their initial angiographic procedure after the three-day interval, 48 (49.5% of 97) had no vasospasm, 31 (32.0%) had localized spasm, and 18 (18.6%) had diffuse vasospasm. Thus, a total of 49 patients (50.5%) had localized or diffuse vasospasm when the initial angiogram was performed four or more days after the last bleed. For all sites combined, this percentage was a 16.5% increase. Particularly during the 8 to 14-day interval ( fig. 3) , the percentage of patients with vasospasm increased appreciably. The appearance of intra-arterial narrowing, as demonstrated by cerebral angiography, had its peak incidence during that interval.
Neurological Condition
Correlation of neurological deficit with specific degree of vasospasm reveals that patients in poor neurological condition (grades 3, 4, and 5) had a greater frequency of localized and diffuse arterial narrowing. Among various neurological conditions 30.6% of patients in grade 2 had localized or severe vasospasm, 65.7% in grade 3, and 58.8% in grade 4 (table 27). Comparison of good condition patients (grades 1 and 2) with those in poor condition (grades 3, 4, and 5) reveals that in the former group 32.1% (43 of 134) had vasospasm (mostly localized), whereas 65.0% (39 of 60) of those in the latter group had localized or diffuse vasospasm in similar proportions (table 27). The frequency and severity of arterial narrowing were significantly increased (P < 0.001) in poor condition patients. •No information on one, making a total of 195.
Mean Blood Pressure
Mean blood pressures were calculated, using the data compiled for systolic and diastolic determinations. In order to determine the relationship of vasospasm to systolic and diastolic values, mean blood pressure distribution was compared with various degrees of vasospasm. 
Mortality
Increased mortality and degree of vasospasm were related to poor neurological condition. The relationship of mortality to various degrees of vasospasm was also analyzed. In patients with no vasospasm, 52.3% died among all aneurysm sites combined. This figure compares with 57.4% and 61.5% among those patients with localized and diffuse vasospasm, respectively (table 31) . Therefore, vasospasm itself was unrelated to mortality on a statistical basis.
Summary of Vasospasm Data
The role of vasospasm in the production of neurological dysfunction in patients with subarachnoid hemorrhage has not been fully investigated in this study, and only some bleed to the beginning of treatment, 42 patients with an aneurysm at the junction of the internal carotid and posterior communicating artery were treated with six weeks of bed rest. Six months after the bleed, 35.7% had died. In the present study 48.6% (18 of 37) died during the six-month interval following last bleed. With regard to patients with a middle cerebral aneurysm, 9 36.9% died within six months after the last bleed. In this study 50.0% (11 of 22) died during that interval. Mortality in patients with an anterior cerebral-anterior communicating aneurysm in the randomized trial of McKissock et al. 10 was 39.8% (61 of 153) at six months (28.7% died following a rebleed within 28 days after the last bleed). In this study aneurysms on the anterior cerebralanterior communicating complex had a cumulative mortality of 23.1% at four weeks, 30.0% at the end of six weeks, and 39.2% (51 of 130) at six months. These figures compare favorably with the series from London for each aneurysm site.
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Recurrent hemorrhage within two months after the bleed has been the major cause of death in many published reports of unoperated patients. In undifferentiated subarachnoid hemorrhage reviewed by Pakarinen," an average of 32.3% rebled within eight weeks after their initial bleed, the major proportion occurring in the second and third weeks (10.1% and 8.0%, respectively). In Pakarinen's series of patients who had a proved aneurysm (107), including preoperative recurrences in patients eventually treated operatively, 83 patients (77.5%) had a recurrent bleed within eight weeks. Fourteen (13.1%) occurred during the first week, 19 (17.8%) during the second, 14 (13.1%) during the third, and 21 (19.6%) during the fourth. Therefore, a total of 63.5% rebled within four weeks, with an additional 14.0% in the following two weeks. This high rebleed rate shows the importance of differentiating subarachnoid hemorrhage due to ruptured aneurysm alone, rather than including all cases in an undifferentiated series. In addition, the influence of patient selection (nonsurgical patients) was also apparent. Furthermore, aneurysm location can be influential. In the randomized series 2 of 42 conservatively treated patients with an internal carotid aneurysm, 21 (50%) rebled within six weeks, and 15 of these died (71.4%, 15 of 21). Most of them (12) occurred during the four to six-week interval. In the present study five patients (14.3%) with an internal carotid aneurysm rebled within two weeks, six (17.1%) in four weeks, and nine (25.7%) in six weeks, with no further rebleeds to the end of the eight-week interval. Essentially, these percentages relate the number of rebleeds which occurred during treatment with bed rest. Twenty-six patients began their official period of bed rest within seven days after last bleed. However, when consideration was given to the number of rebleeds which occurred during the interval prior to hospitalization, eight patients had clinical neurological symptoms or signs of an initial bleed during a 60-day interval preceding the bleed prompting admission to the reporting hospital. Among all 37 patients with an internal carotid aneurysm, eight had two bleeds prior to official commencement of bed rest. Nine additional patients rebled within six weeks after entry into the study. Therefore, a total of 17 patients (48.6%) with recurrent hemorrhage were reported over a period of 14 weeks.
Analysis of those patients from the study who started their bed rest program within seven days after the last bleed showed that five of 26 patients (20.0%) rebled in 14 days, six (24.0%) rebled within four weeks, and a total of nine (36.0%) in eight weeks. The rebleed rate among patients with an internal carotid aneurysm in the Cooperative Study" (nonrandomized) was 19.6% (70 of 358) at 14 days and 24.3% (87 of 358) at the end of 28 days (four weeks). The rebleed rate at the six-week interval was not reported.
In the randomized trial of McKissock et al.,' 18 of 55 (32.7%) conservatively treated patients with a middle cerebral aneurysm rebled during the initial two-week interval, 40.0% (22 of 55) during the three-week interval, and 41.8% (23 of 55) during the four-week interval with no recurrent hemorrhages to the end of six weeks. In the present study 13.6% (3 of 22) rebled during the initial 14-day period, 36.4% (8 of 22) at 30 days, with no further rebleeds to the end of six weeks. In the Cooperative Study series" (nonrandomized), 13.8% (49 of 355) rebled during the 14-day interval, and 16.9% (60 of 355) by the end of four weeks. The data at six weeks were not reported
The randomized series 10 of anterior communicating aneurysms treated conservatively had a rebleed rate of 24.2% (37 of 153) during the first 14 days, with 34.6% (53 of 153) having a rebleed during the four-week interval following the bleed prior to hospitalization. In the present study 16.2% (21 of 130) rebled during the first two weeks following last bleed and a total of 27.7% (36 of 130) within 30 days. In the previous Cooperative Study," 19.2% (130 of 530) rebled within 14 days and 27.0% (143 of 530) within four weeks. No statistical differences were observed among the three studies at these intervals following the bleed.
Mortality among patients following recurrent hemorrhages in the previous Cooperative Study" was 46% for internal carotid aneurysms, 41% for middle cerebral aneurysms, and 42% for anterior cerebral-anterior communicating aneurysms. In the present study death due to rebleeding at 30 days was 14.3% (5 of 35) for patients with an internal carotid aneurysm, 31.8% (7 of 22) for those with a middle cerebral aneurysm, and 19.2% (25 of 130) for patients with an anterior cerebral-anterior communicating aneurysm. In Pakarinen's series" 77.5% died following recurrent hemorrhage. Mortality during the six-week interval in the conservatively treated patients in the randomized trial 8 ' *• 7 among those who had a second bleed was 50.0% (21 of 42, category B) for patients with an internal carotid aneurysm, 32.7% (18 of 55) for those with a middle cerebral aneurysm, and 34.0% (52 of 153) for the anterior cerebralanterior communicating group. In general, mortality of nonsurgically treated patients is lower in studies conducted with a design of randomization in comparison with the number of deaths reported from a nonrandomized selection.
The wide spectrum of clinical manifestations of subarachnoid hemorrhage following ruptured intracranial aneurysm was confirmed in this investigation. Most patients were in good neurological condition after their initial bleed. Sixtyseven per cent were in grades 1 and 2,19.5% (38 of 195) were in grade 3, and 13.3% (26 of 195) were lethargic with varying degrees of neurological deficit (grades 4 and 5). The number of patients with severe central nervous system deficits from the initial rupture was small. More patients experience minimal symptoms frequently, which is consistent with minor bleeding episodes. A recent report" suggests that such symptoms occur in 21.4% (24/112) as a warning sign. In the present study 14.8% (30/202) had a recent history of symptoms characterized by headache or neck or back pain as manifestations of meningeal irritation. In at least threefourths of patients with initial rupture of an intracranial aneurysm, symptoms and signs are relatively minor. By far, the most typical presentation was that complex of symptoms shown by patients in grade 2, namely, severe headache, meningeal signs, and varying degrees of nausea and vomiting, with a transient episode of amnesia in some instances.
Sex distribution has been of particular interest among patients with an internal carotid-posterior communicating aneurysm. For this treatment category 8 were males, and 27 were females. This distribution was similar among all four treatment categories. Sex distribution among patients with a middle cerebral and anterior cerebral-anterior communicating aneurysm was nearly equal. The reason for this peculiar distribution of more females among patients with rupture of an internal carotid aneurysm remains unexplained.
Among 76 patients who rebled, 65 died. Twenty-eight patients (37.8%, table 16) rebled during the interval from the fifth through the fourteenth day following last bleed. The most crucial interval was this period. A unique feature was the distribution of rebleeds among patients with an anterior cerebral-anterior communicating aneurysm. These patients continued to have the most prolonged interval to recurrent hemorrhage, an observation which remains unexplained.
This study appraises and confirms the variation in intervals to recurrent hemorrhages among aneurysm sites. At one end of this spectrum were the so-called "minor bleeds" which may herald a warning sign an average of two weeks prior to the more severe ictus. 12 At the opposite end were those who had one severe hemorrhagic catastrophe with devastating effects to the central nervous system at the initial rupture. Between these two extremes was the large group of patients with symptoms characterized by headache, nausea, vomiting, and usually transient loss of consciousness which prompted medical attention. This group comprised nearly 70% of the entire patient population.
Particular attention must be focused on those patients who had their workup completed and were allocated to therapy within seven days following subarachnoid hemorrhage. This group probably provides the most important information with respect to the number of concrete observations that are associated with subarachnoid hemorrhage following a ruptured intracranial aneurysm. In the group with minor symptoms, too many factors may not appear clinically distinct from other common disorders. In the severe catastrophic lesions, the central nervous system was too extensively and too rapidly damaged to make a definite course of therapy of any value. Patients allocated to treatment within seven days after last bleed had the highest death rate during the fifth through twentieth day ( fig. 2 ). During this interval rebleeding was the most frequent cause of death for all aneurysm sites. Patients allocated to treatment after the seven-day interval were distributed similarly among the various neurological conditions as compared with those patients allocated to treatment within seven days. With 66% of all patients allocated to treatment during the seven-day interval, the risk of rebleeding was most substantial among patients with an internal carotid aneurysm, followed by those with a middle cerebral aneurysm. Patients with an anterior cerebralanterior communicating aneurysm had the slowest rate of recurrent hemorrhage.
Various medical conditions which were present prior to rupture were relatively infrequent. The most frequent condition prior to rupture was pre-existing hypertension. Only 18% had known hypertension, a frequency which would not lead one to designate hypertension as an underlying cause for an aneurysm to rupture. Mortality in this group was 61.1%, a percentage not significantly different from the gross mortality of 55.1%. After the last bleed 124 were allocated to treatment within 7 days, 49 during the 8 to 21-day interval, and 14 during the 22 to 92-day interval.
2. Thirty-seven patients had a single aneurysm on the intracranial portion of the internal carotid system, 23 had an aneurysm on the middle cerebral distribution, 135 on the anterior cerebral-anterior communicating complex, and 7 on the vertebral-basilar system. There were 90 men and 112 women.
3. Eight patients failed to receive their designated treatment. Subtracting these eight patients in addition to the seven with a vertebral-basilar aneurysm allowed a remainder of 187 for correlative analysis.
4. During the mean follow-up interval of 6.5 years, mortality was 55.1%. Cumulative mortality was 62.9% for those patients randomized within 7 days, 40.8% for those randomized during the 8 to 21-day interval, and 35.7% for those allocated to treatment during the 22 through 92-day interval.
5. Eleven patients in grade 1 neurological condition had a 36.4% mortality. Among 117 patients in grade 2,48.7% died; among 36 patients in grade 3 and 15 patients in grade 4, 66.7% died, and among 7 patients in grade 5, all died.
6. For all aneurysm sites a proved rebleed was the cause of death in 34.2%, progressive deterioration from aneurysm rupture in 8.0%, and a suspected rebleed in 4.8%. A total of 47.1 % died from causes related directly to the cerebral effects of the ruptured aneurysm.
7. Mortality in good medical condition patients was not significantly different in the groups below or above age 50. Among patients in fair and poor medical conditions, mortality above age 50 was significantly higher than for those below that age.
8. For all aneurysm sites patients allocated to bed rest within seven days after last bleed had the highest mortality and rebleed rate.
9. In 37.4% of patients several medical disorders needed medical attention during the treatment period. The most frequent conditions were pulmonary or genitourinary tract infections.
10. Unexpected deterioration in neurological condition occurred during or within 24 hours after angiography in 10.8%. Mortality associated with this procedure was 2.6%.
11. 12. For patients in good neurological condition (grades 1 and 2), 32.1% had vasospasm, whereas in poor condition patients (grades 3, 4, 5), 65.0% had some degree of vasospasm.
13. Systolic and mean blood pressures were statistically unrelated to the frequency or severity of vasospasm.
14. Aneurysm size was unrelated statistically to the incidence of vasospasm.
15. Mortality among patients with no vasospasm was 52.3%. In the group of patients with localized vasospasm, 57.4% died. In patients with diffuse vasospasm, the mortality was 61.5%.
